Harmony Biosciences Holdings (HRMY) Prepaid Assets (2019 - 2026)
Harmony Biosciences Holdings' (HRMY) quarterly Prepaid Assets came in at $16.8 million in Q1 2026, up 2.01% year-on-year from $16.5 million in Q1 2025, and up 4.91% quarter-over-quarter from $16.0 million in Q4 2025.
Harmony Biosciences Holdings (HRMY) Prepaid Assets (2019 - 2026) Analysis & Trends
Harmony Biosciences Holdings has disclosed Prepaid Assets across 8 years of filings, most recently posting $16.8 million for Q1 2026.
- Prepaid Assets for Q1 2026 came in at $16.8 million, up 2.01% year-over-year; the trailing twelve-month figure through Mar 2026 was $16.8 million (up 2.01% YoY), and the FY2025 annual result was $16.0 million, up 97.19% from the prior year.
- Prepaid Assets came in at $16.8 million for Q1 2026 at Harmony Biosciences Holdings, up from $16.0 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $35.4 million in Q3 2025 to a low of $3.4 million in Q1 2022.
- The 5-year median for Prepaid Assets is $10.8 million (2022), against an average of $12.1 million.
- Peak annual rise in Prepaid Assets reached 594.48% in 2022, while the deepest fall reached 58.05% in 2022.
- Harmony Biosciences Holdings' Prepaid Assets stood at $8.8 million in 2022, then soared by 43.07% to $12.6 million in 2023, then sank by 35.39% to $8.1 million in 2024, then surged by 97.19% to $16.0 million in 2025, then climbed by 4.91% to $16.8 million in 2026.
- The last three Prepaid Assets figures came in at $16.8 million (Q1 2026), $16.0 million (Q4 2025), and $35.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Harmony Biosciences Holdings | 1.92 Bn | 1.28 Bn | 170.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.80 Mn |
| Dec 31, 2025 | 16.01 Mn |
| Sep 30, 2025 | 35.38 Mn |
| Jun 30, 2025 | 8.64 Mn |
| Mar 31, 2025 | 16.47 Mn |
| Dec 31, 2024 | 8.12 Mn |
| Sep 30, 2024 | 7.46 Mn |
| Jun 30, 2024 | 16.13 Mn |
| Mar 31, 2024 | 8.68 Mn |
| Dec 31, 2023 | 12.57 Mn |
| Sep 30, 2023 | 14.27 Mn |
| Jun 30, 2023 | 6.55 Mn |
| Mar 31, 2023 | 11.40 Mn |
| Dec 31, 2022 | 8.79 Mn |
| Sep 30, 2022 | 4.11 Mn |
| Jun 30, 2022 | 10.83 Mn |
| Mar 31, 2022 | 3.41 Mn |
| Dec 31, 2021 | 3.22 Mn |
| Sep 30, 2021 | 9.79 Mn |
| Jun 30, 2021 | 1.56 Mn |